CompletedPHASE1, PHASE2NCT00593138

Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate

Studying Chronic bilirubin encephalopathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Principal Investigator
Thomas Spencer, MD
MGH
Intervention
dex-methylphenidate(drug)
Enrollment
23 enrolled
Eligibility
18-55 years · All sexes
Timeline
2006 – 2009

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00593138 on ClinicalTrials.gov

Other trials for Chronic bilirubin encephalopathy

Additional recruiting or active studies for the same condition.

See all trials for Chronic bilirubin encephalopathy →

← Back to all trials